Literature DB >> 9096806

Hemolysis in different centrifugal pumps.

K Kawahito1, Y Nosé.   

Abstract

Different types of centrifugal pumps cause different amounts of hemolysis based on shear stress and blood exposure time. However, the hemolytic characteristics of centrifugal pumps in each clinical condition are not always clear. We compared the hemolytic characteristics of one cone-type centrifugal pump (Medtronic BioMedicus BP-80) and 2 impeller-type centrifugal pumps (Nikkiso HMS-12 and Terumo Capiox) under experimental conditions simulating their use in cardiopulmonary bypass (CPB), extracorporeal membrane oxygenation (ECMO), and percutaneous cardiopulmonary support (PCPS) as well as their use as left ventricular assist devices (LVADs). The normalized indexes of hemolysis (NIHs; grams free plasma hemoglobin per 100 L blood pumped) during use as LVADs were not significantly different among the 3 pumps. The BP-80 pump produced almost 3-fold more hemolysis than the HMS-12 and Capiox pumps during CPB, 3- to 4-fold more hemolysis during ECMO, and 5.5-fold more hemolysis during PCPS. The 2 impeller-type centrifugal pumps will therefore cause less hemolysis under high flow, high pressure difference (as in CPB) and low flow, high pressure difference (as in ECMO and PCPS) conditions than the cone-type pump.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9096806     DOI: 10.1111/j.1525-1594.1997.tb00369.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  8 in total

1.  Multilaboratory study of flow-induced hemolysis using the FDA benchmark nozzle model.

Authors:  Luke H Herbertson; Salim E Olia; Amanda Daly; Christopher P Noatch; William A Smith; Marina V Kameneva; Richard A Malinauskas
Journal:  Artif Organs       Date:  2014-09-02       Impact factor: 3.094

Review 2.  Trends in and perspectives on extracorporeal membrane oxygenation for severe adult respiratory failure.

Authors:  Tomohito Sadahiro; Shigeto Oda; Masataka Nakamura; Yo Hirayama; Eizo Watanabe; Yoshihisa Tateishi; Koichiro Shinozaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-03-28

Review 3.  Anticoagulation Therapy during Extracorporeal Membrane Oxygenator Support in Pediatric Patients.

Authors:  Hwa Jin Cho; Do Wan Kim; Gwan Sic Kim; In Seok Jeong
Journal:  Chonnam Med J       Date:  2017-05-25

4.  Erythrocyte-protective effect of sarpogrelate hydrochloride (Anplag ®), a selective 5-HT2 receptor antagonist: an in vitro study.

Authors:  Ken Nakamura; Koji Kawahito
Journal:  J Artif Organs       Date:  2010-08-27       Impact factor: 1.731

5.  The Influence of Impeller Geometries on Hemolysis in Bearingless Centrifugal Pumps.

Authors:  Pascal Puentener; Marcel Schuck; Johann W Kolar
Journal:  IEEE Open J Eng Med Biol       Date:  2020-11-16

6.  Computational modeling of the Food and Drug Administration's benchmark centrifugal blood pump.

Authors:  Bryan C Good; Keefe B Manning
Journal:  Artif Organs       Date:  2020-02-16       Impact factor: 3.094

7.  Durability improvement of polymer chamber of pulsatile extracorporeal life support system in terms of mechanical change.

Authors:  Hyuk Choi; Seung Hoon Paik; Kwang Ho Lee; Byoung Goo Min; Yong Soon Won
Journal:  Med Biol Eng Comput       Date:  2007-08-25       Impact factor: 3.079

8.  Membrane Lung and Blood Pump Use During Prolonged Extracorporeal Membrane Oxygenation: Trends From 2002 to 2017.

Authors:  McKenzie M Hayes; Brian P Fallon; Ryan P Barbaro; Niki Manusko; Robert H Bartlett; John M Toomasian
Journal:  ASAIO J       Date:  2021-09-01       Impact factor: 3.826

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.